drugset / Trial / NCT00253149

A Study of the Effectiveness and Safety of Risperidone as add-on Therapy to Mood Stabilizers in the Treatment of Manic Episodes Associated With Bipolar Disorder

NCT00253149

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of the study is to evaluate the effectiveness and safety of risperidone (an antipsychotic medication) versus placebo as add-on therapy to mood stabilizers in the treatment of manic episodes associated with bipolar disorder.

Timeline

Start
Primary completion
Completion
1999-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Risperidone Other / unclassified 3.8 mg Oral